QLINES logo

Q-linea BATS-CHIXE:QLINES Stock Report

Last Price

SEK 4.78

Market Cap

SEK 380.9m

7D

0%

1Y

-81.0%

Updated

18 Nov, 2023

Data

Company Financials +

Q-linea AB (publ)

BATS-CHIXE:QLINES Stock Report

Market Cap: SEK 380.9m

QLINES Stock Overview

Engages in the development of instruments and consumables for infection diagnostics in the United Kingdom. More details

QLINES fundamental analysis
Snowflake Score
Valuation1/6
Future Growth5/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Q-linea AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for Q-linea
Historical stock prices
Current Share PriceSEK 4.78
52 Week HighSEK 8.10
52 Week LowSEK 4.78
Beta1.05
1 Month Change0%
3 Month Changen/a
1 Year Change-80.96%
3 Year Change-96.95%
5 Year Changen/a
Change since IPO-91.52%

Recent News & Updates

Recent updates

Shareholder Returns

QLINESGB Medical EquipmentGB Market
7D0%-2.3%-2.2%
1Y-81.0%-10.6%2.4%

Return vs Industry: QLINES underperformed the UK Medical Equipment industry which returned -7.4% over the past year.

Return vs Market: QLINES underperformed the UK Market which returned -2.4% over the past year.

Price Volatility

Is QLINES's price volatile compared to industry and market?
QLINES volatility
QLINES Average Weekly Movementn/a
Medical Equipment Industry Average Movement6.5%
Market Average Movement4.8%
10% most volatile stocks in GB Market10.5%
10% least volatile stocks in GB Market2.6%

Stable Share Price: QLINES has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine QLINES's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2007122Jonas Jarviusqlinea.com

Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in the United Kingdom. It offers ASTar, an antibiotic susceptibility testing system used for positive blood cultures; and in vitro diagnostics systems for infectious diseases. The company serves healthcare providers.

Q-linea AB (publ) Fundamentals Summary

How do Q-linea's earnings and revenue compare to its market cap?
QLINES fundamental statistics
Market capSEK 380.89m
Earnings (TTM)-SEK 238.80m
Revenue (TTM)SEK 6.32m

60.2x

P/S Ratio

-1.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
QLINES income statement (TTM)
RevenueSEK 6.32m
Cost of RevenueSEK 8.63m
Gross Profit-SEK 2.31m
Other ExpensesSEK 236.49m
Earnings-SEK 238.80m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-2.04
Gross Margin-36.53%
Net Profit Margin-3,776.69%
Debt/Equity Ratio0%

How did QLINES perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/11/18 13:14
End of Day Share Price 2023/08/21 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Q-linea AB (publ) is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Ulrik TrattnerCarnegie Investment Bank AB
Alexandru CogutKempen & Co. NV